You’ll Want to Buy This Stock Before April 30th
This is one of the most exciting developments I’ve seen in years…
Not only is a new cancer treatment poised to revolutionize the war on cancer, but it could be the single best investment move you can make this decade.
Let me tell you why.
Unlike chemo or radiation, this treatment harnesses your body’s immune system to identify and kill tumors—without harming healthy cells.
Back when I was finishing my medical residency in the early ‘80s, ideas like this were all just theory.
Now it’s not just a reality—it’s already saving lives.
The powerful “Alpha Cells” that are used as part of this treatment are like the “conductor of the immune system orchestra.” Or the “general of the immune system army.”
Think of cancer as a powerful enemy within the gates. And whereas most new cancer therapies send out a platoon or squad against it—and lose—“Alpha Cells” instead command our body’s entire armed defenses.
That includes killer T-Cells, B-Cells, macrophages—pretty much every anti-cancer cell in our body.
Immune fighters that are lying dormant because the cancer cells have either evaded or deactivated them.
Only “Alpha Cells” are able to rally them to attack—eliminating cancer throughout the body.
That’s what makes this approach so unique. And why this discovery won the Nobel Prize.
The problem is, our bodies don’t make enough “Alpha Cells” to mount a significant immune response against cancer.
So our immune system sits idle, like an army without a leader, as cancer cells wreak havoc on our bodies.
“Alpha Cells” change all of that.
Scientists put them back into action using this new therapy.
First, scientists isolate “Alpha Cells” and train them to identify and target cancer cells.
Then they marshal our T-Cell and B-Cell immune fighters against the cancer.
But it gets even better…
It Doesn’t Just Destroy Cancer Cells…It Makes Sure They Never Return
You see, “Alpha Cells” reprogram our immune system for a foolproof adaptive response to future cancer threats.
Imagine your home is invaded by a burglar, but you’re able to scare him off.
Then you buy a security system for your home, so you’re better prepared the next time. That’s an adaptive response.
Your immune system also learns from its encounters with invaders—and then prepares for the next round.
It does this by “remembering” how to distinguish an invader from a harmless cell. That way it can pick the invader out in a crowd and head right for it.
Duke researchers compare “Alpha Cells” to “most wanted” posters for the immune system since they tell the killer T-cells exactly which antigens to go after.
Think again of the invader in your home. Imagine you were able to get his picture. Or maybe you already had a security system that captured his image on video. You circulate his picture to your neighbors, so next time he’s seen in the neighborhood, he’s reported immediately. He never even gets near your house.
Now that’s a really adaptive response!
And that’s why so many patients have not just defeated cancer, but gone into complete, long-term remission…
Living lives cancer-free for years, even decades.
Clinical Trials Are Proving “Alpha Cells” Can Even Cure Stage 4 Cancer Patients
Clinical trials by some of America’s biggest scientific institutions have confirmed with hard evidence just how powerful this breakthrough is.
Stanford University led the charge with studies right when “Alpha Cells” were first discovered.
The thirty-one lymphoma patients who took part in the 20-year study are still alive today.
The Wall Street Journal called the results a “seismic shift in cancer research.”
Recently, Duke University researchers used “Alpha Cells” to target the ultra-lethal brain cancer—a glioblastoma.
And the results were incredible…
Remember, these patients have only months to live.
But over half of the patients treated in the Duke study survived for 5 years or longer.
Just imagine. If this therapy can defeat the most lethal, untreatable form of brain cancer, what could it do for other kinds of cancer?
It might not be long before we find out.
In the coming weeks, we’re expecting another important announcement to come from the company developing this treatment.
And that’s not just a good thing for patients.
I can tell you without reservation: the company behind this development offers phenomenal upside potential— among the biggest and most urgent I’ve seen in years.
I believe it’s positioned to become a go-to treatment for all kinds of cancer— replacing chemo and radiation.
And why it could grab a HUGE share of the $91 billion spent every year on cancer care.
All of this is why the tiny stock at the center of this technology is already starting to take off…
But I think it has much higher to go. And starting as soon as April 30th — as a final read on clinical trials is released…we could see this stock explode to the upside.
Click here now to get the full details on this company.